chr18-62154538-CACAAACCT-C

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_176787.5(PIGN):​c.548_549+6delAGGTTTGT​(p.Lys183fs) variant causes a frameshift, splice donor, splice region, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000325 in 1,345,956 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00035 ( 0 hom. )

Consequence

PIGN
NM_176787.5 frameshift, splice_donor, splice_region, intron

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 8.36

Publications

1 publications found
Variant links:
Genes affected
PIGN (HGNC:8967): (phosphatidylinositol glycan anchor biosynthesis class N) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]
PIGN Gene-Disease associations (from GenCC):
  • multiple congenital anomalies-hypotonia-seizures syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
  • Fryns syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 18-62154538-CACAAACCT-C is Pathogenic according to our data. Variant chr18-62154538-CACAAACCT-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 264637.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGNNM_176787.5 linkc.548_549+6delAGGTTTGT p.Lys183fs frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant Exon 7 of 31 ENST00000640252.2 NP_789744.1 O95427A0A024R2C3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGNENST00000640252.2 linkc.548_549+6delAGGTTTGT p.Lys183fs frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant Exon 7 of 31 1 NM_176787.5 ENSP00000492233.1 O95427
PIGNENST00000400334.7 linkc.548_549+6delAGGTTTGT p.Lys183fs frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant Exon 6 of 30 1 ENSP00000383188.2 O95427
PIGNENST00000638424.1 linkn.548_549+6delAGGTTTGT splice_donor_variant, splice_region_variant, intron_variant, non_coding_transcript_exon_variant Exon 5 of 29 5 ENSP00000491963.1 A0A1W2PQZ1

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
151714
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000130
AC:
32
AN:
245596
AF XY:
0.000143
show subpopulations
Gnomad AFR exome
AF:
0.0000649
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000259
Gnomad OTH exome
AF:
0.000333
GnomAD4 exome
AF:
0.000353
AC:
421
AN:
1194242
Hom.:
0
AF XY:
0.000318
AC XY:
193
AN XY:
607212
show subpopulations
African (AFR)
AF:
0.0000709
AC:
2
AN:
28220
American (AMR)
AF:
0.00
AC:
0
AN:
43682
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24402
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38358
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79402
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52764
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5274
European-Non Finnish (NFE)
AF:
0.000463
AC:
403
AN:
870736
Other (OTH)
AF:
0.000311
AC:
16
AN:
51404
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
20
40
61
81
101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
151714
Hom.:
0
Cov.:
32
AF XY:
0.0000809
AC XY:
6
AN XY:
74124
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41052
American (AMR)
AF:
0.00
AC:
0
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
67998
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000174
Hom.:
0
Bravo
AF:
0.000136

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multiple congenital anomalies-hypotonia-seizures syndrome 1 Pathogenic:4
Sep 28, 2016
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 25, 2024
Johns Hopkins Genomics, Johns Hopkins University
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This PIGN variant (rs779636222) is rare (<0.1%) in a large population dataset (gnomAD: 36/276898 total alleles; 0.013%; no homozygotes) and has an entry in ClinVar. It has been reported in one individual with multiple congenital anomalies-hypotonia-seizures syndrome in a compound heterozygous state with another pathogenic variant. This 8-bp deletion (ACAAACCT) covers two coding nucleotides and six intronic nucleotides, including the canonical splice donor site and is predicted to cause aberrant pre-mRNA splicing. We consider c.548_549+6del to be pathogenic for autosomal recessive multiple congenital anomalies-hypotonia-seizures syndrome-1. -

Jun 23, 2021
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant results in the deletion of part of exon 7 (c.548_549+6del) of the PIGN gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PIGN are known to be pathogenic (PMID: 24253414, 27038415). This variant is present in population databases (rs779636222, gnomAD 0.03%). This variant has been observed in individual(s) with clinical features of multiple congenital anomalies-hypotonia-seizures syndrome (PMID: 26394714, 30293990, 30609409). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 264637). For these reasons, this variant has been classified as Pathogenic. -

not provided Pathogenic:2
Apr 26, 2017
Eurofins Ntd Llc (ga)
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 26, 2022
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Canonical splice site variant predicted to result in a null allele in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27038415, 24253414, 26394714, 30609409, 30293990) -

Inborn genetic diseases Pathogenic:1
Jan 03, 2018
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.548_549+6delAGGTTTGT pathogenic mutation, located at the 3' end of coding exon 4 in the PIGN gene, results from a deletion of 2 coding nucleotides and 6 intronic nucleotides at positions c.548 to c.549+6, including the canonical donor site. In one study, this mutation was detected in an individual with multiple congenital anomalies-hypotonia-seizures syndrome who also carried a second PIGN alteration in trans (a gross deletion encompassing multiple exons) (Fleming, L. 2016. Am. J. Med. Genet. A 2016 Jan;170A(1):77-86). In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -

Multiple congenital anomalies-hypotonia-seizures syndrome Pathogenic:1
May 10, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.548_549+6delAGGTTTGT variant in PIGN has been reported in one patient with multiple congenital anomalies-hypotonia-seizures syndrome in a compound heteroz ygous state (Fleming 2016) and has been identified in 13/120594 chromosomes by t he Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). Although this variant has been seen in the general population, its frequency is low enou gh to be consistent with a recessive carrier frequency. This deletion encompasse s the invariant region (+/- 1,2) of the splice consensus sequence and is predict ed to cause altered splicing leading to an abnormal or absent protein. Biallelic loss of function of the PIGN gene has been associated with multiple congenital anomalies-hypotonia-seizures syndrome. In summary, although additional studies a re required to fully establish its clinical significance, the c.548_549+6del var iant in PIGN is likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
8.4
Mutation Taster
=3/197
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779636222; hg19: chr18-59821771; API